Skip to main content
Clinical Trials/NCT04857476
NCT04857476
Active, not recruiting
Not Applicable

Do Patients With Skin PSoriasis Have Sub-clinical Features of ACTive Psoriatic Arthritis on Musculoskeletal UltraSound?

The Royal Wolverhampton Hospitals NHS Trust1 site in 1 country130 target enrollmentJune 8, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Psoriatic Arthritis
Sponsor
The Royal Wolverhampton Hospitals NHS Trust
Enrollment
130
Locations
1
Primary Endpoint
PEST Scores
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

Psoriatic Arthritis is an inflammatory condition that typically affects joints and soft tissues such as tendons. Poorly controlled or untreated psoriatic arthritis can lead to joint damage, disability and poor physical and mental wellbeing. Evidence suggests that early diagnosis and treatment of psoriatic arthritis can minimise adverse health outcomes.

Musculoskeletal ultrasound has become an extremely useful tool in aiding rheumatologists to diagnose inflammatory joint conditions particularly at an early stage in the course of a disease.

Psoriatic arthritis is known to affect up to 30% of patients with skin psoriasis. Therefore, national dermatology guidelines advise that patients with skin psoriasis should be asked about any joint symptoms at least every year.

This study investigates whether skin psoriasis patients who are not on biologic treatment are indeed being asked about any joint symptoms and we subsequently invite patients for a musculoskeletal ultrasound scan to see if they have features of early psoriatic arthritis on ultrasound. Those who do are then invited for a thorough rheumatology clinical assessment.

Registry
clinicaltrials.gov
Start Date
June 8, 2021
End Date
June 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of Psoriasis by a dermatologist
  • Aged 18 or more
  • Reasonable fluency of spoken English

Exclusion Criteria

  • Existing diagnosis of Psoriatic arthritis
  • Currently on biologics for treatment of their skin Psoriasis (as this would potentially treat and thereby diminish joint symptoms associated with PsA)
  • Aged \<18years old (the study focusses on an adult population)
  • Currently in prison (would be unable to attend the study ultrasound scan)
  • Unable to give written consent for a musculoskeletal ultrasound e.g. advanced dementia, learning difficulties (may be unable to appreciate the reason for the study and may be unable to tolerate sitting relatively still for an ultrasound scan for 60 minutes)

Outcomes

Primary Outcomes

PEST Scores

Time Frame: 3 years

To identify whether patients who have higher PEST scores are more likely to have features of psoriatic arthritis on ultrasound

PEST score element

Time Frame: 3 years

Which element of a PEST score, if reported by a patient, is most likely to be associated with features of psoriatic arthritis on musculoskeletal ultrasound

High PEST score with normal ultrasound scan

Time Frame: 2 years

Are patients with a high PEST score and a normal initial musculoskeletal ultrasound scan more likely to be diagnosed with Psoriatic arthritis after 2 years

Proportion of patients with known skin psoriasis have features in keeping with psoriatic arthritis on musculoskeletal ultrasound

Time Frame: 3 years

proportion of patients with known skin psoriasis have features in keeping with psoriatic arthritis on musculoskeletal ultrasound

Risk factors associated with those psoriasis patients who do have features of psoriatic arthritis on musculoskeletal ultrasound

Time Frame: 3 years

Are there any particular risk factors associated with those psoriasis patients who do have features of psoriatic arthritis on musculoskeletal ultrasound?

Study Sites (1)

Loading locations...

Similar Trials